Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 28, 1998

View Archived Issues

Blocking Presenilin Gene Studied To Battle Alzheimer's

UK Firm Tackles Diabetes With Phosphoglycokines

Tasmanian Families To Serve As Lab For Disease Gene Discovery

Danish Biotechnology Sector In Line For US$50M Boost

Allelix Expands Lilly Alliance; Suspends Hoechst Program

Amrad Reports Positive Phase I Data On Neurological Drug

Irish Stores First To Employ BSE Test To Evaluate Beef

Oxford Asymmetry Seeks £20M In Listing On London Exchange

IDM Gets First CE Mark For Cell Processor

Other News to Note

Elan Reports Positive Data In Phase II Trial For Antegren

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...